Serological relationships among subgroups in bovine viral diarrhea virus genotype 1 (BVDV-1)


Alpay G., YEŞİLBAĞ K.

VETERINARY MICROBIOLOGY, cilt.175, sa.1, ss.1-6, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 175 Sayı: 1
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.vetmic.2014.10.034
  • Dergi Adı: VETERINARY MICROBIOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1-6
  • Anahtar Kelimeler: Bovine viral diarrhea virus, BVDV-1, Cross neutralization, Serological relation, Subgroup, ANTIGENIC DIVERSITY, FETAL PROTECTION, INFECTION, IDENTIFICATION, HETEROGENEITY, SUBGENOTYPES, VACCINATION, EXPOSURE, FAILURE, DISEASE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Bovine viral diarrhea virus (BVDV) has various economic impacts associated with diarrhea, poor performance, an increase in the frequency of other infections and lethal outcomes. Both genotypes, namely BVDV-1 and BVDV-2, as well as different subgroups within these genotypes have been reported worldwide. Understanding the serological differences among the BVDV subgroups is important for disease epidemiology and prevention as well as vaccination programs. The aim of this study was to determine the serological relatedness among the subgroups in BVDV-1. For that purpose, sheep hyperimmune sera were collected against representative strains from 6 of the subgroups of BVDV-1 (BVDV-1a, -1b, -1d, -1f, -1h and -1l). The serum samples that gave the peak antibody titer to the homologous strains were used to perform cross neutralization assays. The highest homologous antibody titer (1:5160) was obtained against BVDV-1h. Regarding the cross neutralizing (heterologous) antibodies, the lowest titer (1:20) was produced by the BVDV-1f antiserum against the BVDV-1a and BVDV1-b viruses. The highest cross neutralizing titer (1:2580) achieved by the BVDV-1h antiserum was against the BVDV-1b strain. The cross neutralization results indicated particular serological differences between the recently described subgroup (BVDV-1l) and BVDV-1a/-1b, which are widely used in commercial vaccines. Considering the cross neutralization titers, it is concluded that selected BVDV-1l and BVDV-1h strains can be used for the development of diagnostic and control tools. (C) 2014 Elsevier B.V. All rights reserved.